Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cartesian Therapeutics, Inc. - Common Stock (NQ: RNAC ) 24.52 +1.70 (+7.45%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cartesian Therapeutics, Inc. - Common Stock Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases September 25, 2024 Amgen tested its drug, Uplizna, in generalized myasthenia gravis, a market where Argenx's Vyvgart leads. Via Investor's Business Daily RNAC Stock Earnings: Cartesian Therapeutics Beats EPS, Beats Revenue for Q2 2024 August 08, 2024 RNAC stock results show that Cartesian Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session July 05, 2024 Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family Via Benzinga Cartesian Therapeutics Plummets On 'Watershed Moment' For CAR-T Drugs July 02, 2024 The company is the first to test a CAR-T drug against a placebo in patients with an autoimmune disease. Via Investor's Business Daily Cartesian's Autoimmune Disorder Candidate Hits Primary Goal In Mid-Stage Study, Announces Equity Raise Of $130M July 02, 2024 Cartesian Therapeutics reported Phase 2b trial results for Descartes-08 in generalized myasthenia gravis, showing significant improvements in MG Composite scores with a favorable safety profile. The... Via Benzinga RNAC Stock Earnings: Cartesian Therapeutics Misses EPS, Beats Revenue for Q1 2024 May 08, 2024 RNAC stock results show that Cartesian Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace Cartesian Therapeutics Announces New Employment Inducement Grants May 06, 2024 From Cartesian Therapeutics, Inc. Via Business Wire Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 23, 2024 Via Benzinga HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday April 23, 2024 Via Benzinga Cartesian Therapeutics to Present at the ASGCT 27th Annual Meeting April 22, 2024 From Cartesian Therapeutics, Inc. Via Business Wire Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 16, 2024 Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session April 15, 2024 Via Benzinga Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy April 10, 2024 Cartesian Therapeutics' autoimmune disease treatment with re-dosable mRNA CAR-Ts. Learn about Descartes-08, a promising anti-BCMA CAR-T therapy offering deeper, longer-lasting efficacy than current... Via Benzinga Cartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference April 04, 2024 From Cartesian Therapeutics, Inc. Via Business Wire Cartesian Therapeutics Announces New Employment Inducement Grants April 04, 2024 From Cartesian Therapeutics Via Business Wire 12 Health Care Stocks Moving In Thursday's After-Market Session March 28, 2024 Via Benzinga LivePerson And 2 Other Stocks Under $2 Insiders Are Buying March 19, 2024 The Dow Jones index closed higher by around 75 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities RNAC Stock Earnings: Cartesian Therapeutics Misses EPS, Beats Revenue for Q4 2023 March 07, 2024 RNAC stock results show that Cartesian Therapeutics missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. Via InvestorPlace SolarEdge Layoffs 2024: What to Know About the Latest SEDG Job Cuts January 22, 2024 SolarEdge layoffs are coming for 16% of the company's workers as it prepares to reduce its total headcount by 900 employees. Via InvestorPlace Topics Workforce Exposures Layoff Why Is Cartesian Therapeutics (RNAC) Stock Down 5% Today? January 22, 2024 Cartesian Therapeutics stock is falling on Monday as investors react to a delisting notice for RNAC shares due to its low trading price. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday January 22, 2024 We're starting the trading week with a breakdown of the biggest pre-market stock movers worth knowing about on Monday! Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session January 10, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session December 01, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.